Discrete choice experiment with duration versus time trade-off: a comparison of test–retest reliability of health utility elicitation approaches in SF-6Dv2 valuation

Valuation of SF-6Dv2 Health States in China Using Time Trade-off and Discrete-Choice Experiment with a Duration Dimension

(2021) Jing Wu et al.   PHARMACOECONOMICS

The Simplified Chinese version of SF-6Dv2: translation, cross-cultural adaptation and preliminary psychometric testing

(2020) Jing Wu et al.   QUALITY OF LIFE RESEARCH

Valuing the SF-6Dv2 Classification System in the United Kingdom Using a Discrete-choice Experiment With Duration

(2020) Brendan J. Mulhern et al.   MEDICAL CARE

Developing a New Version of the SF-6D Health State Classification System From the SF-36v2

(2020) John E. Brazier et al.   MEDICAL CARE

Do Discrete Choice Experiments Approaches Perform Better Than Time Trade-Off in Eliciting Health State Utilities? Evidence From SF-6Dv2 in China

(2020) Shitong Xie et al.   VALUE IN HEALTH

Test-Retest Reliability of EQ-5D-5L Valuation Techniques: The Composite Time Trade-Off and Discrete Choice Experiments

(2018) Fredrick Dermawan Purba et al.   VALUE IN HEALTH

Test-Retest Reliability of Discrete Choice Experiment for Valuations of QLU-C10D Health States

(2018) Eva-Maria Gamper et al.   VALUE IN HEALTH

Estimating a Dutch Value Set for the Paediatric Preference-Based CHU9D Using a Discrete Choice Experiment with Duration

(2018) Donna Rowen et al.   VALUE IN HEALTH

One Method, Many Methodological Choices: A Structured Review of Discrete-Choice Experiments for Health State Valuation

(2018) Brendan Mulhern et al.   PHARMACOECONOMICS

Australian Utility Weights for the EORTC QLU-C10D, a Multi-Attribute Utility Instrument Derived from the Cancer-Specific Quality of Life Questionnaire, EORTC QLQ-C30

(2017) Madeleine T. King et al.   PHARMACOECONOMICS

Feasibility, comparability, and reliability of the standard gamble compared with the rating scale and time trade-off techniques in Korean population

(2017) Seon-Ha Kim et al.   QUALITY OF LIFE RESEARCH

Using Discrete Choice Experiments with Duration to Model EQ-5D-5L Health State Preferences

(2016) Brendan Mulhern et al.   MEDICAL DECISION MAKING

EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes

(2016) Mark Oppe et al.   PHARMACOECONOMICS

How do women trade-off benefits and risks in chemotherapy treatment decisions based on gene expression profiling for early-stage breast cancer? A discrete choice experiment

(2016) Deborah A Marshall et al.   BMJ Open

A Comparison of Methods for Converting DCE Values onto the Full Health-Dead QALY Scale

(2014) Donna Rowen et al.   MEDICAL DECISION MAKING

AN AUSTRALIAN DISCRETE CHOICE EXPERIMENT TO VALUE EQ-5D HEALTH STATES

(2013) Rosalie Viney et al.   HEALTH ECONOMICS

Valuing SF-6D Health States Using a Discrete Choice Experiment

(2013) Richard Norman et al.   MEDICAL DECISION MAKING

Constructing Experimental Designs for Discrete-Choice Experiments: Report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force

(2013) F. Reed Johnson et al.   VALUE IN HEALTH

Using a discrete choice experiment to estimate health state utility values

(2011) Nick Bansback et al.   JOURNAL OF HEALTH ECONOMICS

Test-retest reliability of health state valuation techniques: the time trade off and person trade off

(2010) Suzanne Robinson   HEALTH ECONOMICS

Discrete Choice Modeling for the Quantification of Health States: The Case of the EQ-5D

(2010) Elly A. Stolk et al.   VALUE IN HEALTH

Feasibility, Reliability, and Validity of Three Health-State Valuation Methods Using Multiple-Outcome Vignettes on Moderate-Risk Pregnancy at Term

(2009) Denise Bijlenga et al.   VALUE IN HEALTH

Conducting Discrete Choice Experiments to Inform Healthcare Decision Making

(2008) Emily Lancsar et al.   PHARMACOECONOMICS